Free Trial

Account Management LLC Buys 4,025 Shares of Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Account Management LLC boosted its stake in Synopsys by 83.9% in Q4, buying 4,025 shares to hold 8,820 shares worth $4.143 million, about 4.4% of the fund's portfolio and its 8th largest position.
  • Analysts have trimmed price targets recently, leaving Synopsys with a consensus rating of "Hold", an average target of $531, and a split of 8 Buy, 8 Hold and 1 Sell ratings.
  • Synopsys beat Q4 expectations (EPS $3.77 vs. $3.56 est.; revenue $2.41B vs. $2.39B), reported revenue up 65.6% year‑over‑year, and provided FY2026 EPS guidance of 14.380–14.460 (Q2: 3.110–3.170).
  • MarketBeat previews top five stocks to own in June.

Account Management LLC lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 83.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,820 shares of the semiconductor company's stock after purchasing an additional 4,025 shares during the quarter. Synopsys accounts for about 4.4% of Account Management LLC's portfolio, making the stock its 8th largest position. Account Management LLC's holdings in Synopsys were worth $4,143,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Alpine Bank Wealth Management grew its position in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock worth $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. raised its position in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock valued at $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Synopsys during the third quarter valued at about $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys during the third quarter valued at about $28,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Synopsys during the fourth quarter valued at about $28,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. HSBC downgraded Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price objective for the company. in a research note on Friday, February 20th. Needham & Company LLC reissued a "buy" rating on shares of Synopsys in a report on Thursday, February 26th. Wells Fargo & Company decreased their price target on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating for the company in a research report on Thursday, February 26th. Morgan Stanley reaffirmed an "equal weight" rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Finally, Rosenblatt Securities cut their price target on shares of Synopsys from $560.00 to $530.00 and set a "buy" rating on the stock in a report on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Synopsys currently has a consensus rating of "Hold" and an average target price of $531.00.

Check Out Our Latest Research Report on SNPS

Synopsys Price Performance

Synopsys stock opened at $482.60 on Friday. The stock's 50 day moving average is $430.07 and its 200 day moving average is $445.72. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The firm has a market cap of $92.45 billion, a P/E ratio of 74.94, a P/E/G ratio of 3.93 and a beta of 1.15. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating analysts' consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company's revenue for the quarter was up 65.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, research analysts expect that Synopsys, Inc. will post 10.3 EPS for the current year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines